Where We Are Headed -- New Outlook on Bristol-Myers Squibb Company and AstraZeneca Plc

Wed Oct 24, 2012 9:00am EDT

* Reuters is not responsible for the content in this press release.

  JAKARTA, INDONESIA, Oct 24 (Marketwire) -- 
Moments ago, NationalTradersAssociation.org introduced new coverage of
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca Plc (NYSE: AZN).
Full outlook, analysis and consensus opinion is available to readers via
the links below.



    The consistent delivery of accurate analyses relies solely on two
factors, namely: market awareness and industry insight. Recent market
drivers include the spark of U.S. housing starts soaring past
expectations to a four-year high in September, industrial production
rising 0.4% in September 2012 beating expectations for a 0.2% increase
and the recent upward surprise in initial jobless claims bouncing upward
to 388,000 above expectations of 365,000 in the latest week. When it
comes to discovering the right edge at the right time, all these factors
play into effect. For a deeper understanding of the mechanics behind
these events and how it can affect your portfolio, please refer to our
email newsletter delivered to your inbox.

    National Traders Association is releasing new coverage on Bristol-Myers
Squibb Company for its current position within the consumer durables
sector. Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical
company. The Company is engaged in the discovery, development, licensing,
manufacturing, marketing, distribution and sale of biopharmaceutical
products on a global basis. A copy of this report featuring Bristol-Myers
Squibb Company (NYSE: BMY) is available at:

    National Traders Association has released research on AstraZeneca Plc for
its changing role within the consumer durables sector. AstraZeneca PLC
(AstraZeneca) is a global biopharmaceutical company. AstraZeneca
discovers, develops and commercializes prescription medicines for six
areas of healthcare: Cardiovascular, Gastrointestinal, Infection,
Neuroscience, Oncology, and Respiratory and Inflammation. To access the
full research report on AstraZeneca Plc (NYSE: AZN) we welcome investors
to visit: www.NationalTradersAssociation.org/r/gov/2770_AZN.

    Consider National Traders Association
 Tired of hearing about the latest,
greatest trade opportunity... only to realize that the ship has long
sailed? You need a strong, informative community in your arsenal. Join
the group that has been consistently identifying momentous situations as
they develop -- long before they become the next top news on major
financial networks.



Demi Lapierre

Copyright 2012, Marketwire, All rights reserved.